Conference abstract · 11 Aug 2016
Conference abstractPublished 11 Aug 2016
Novel methodology of detecting minimal residual disease in acute leukemia by using FTIR spectroscopy
King Abdulaziz University Hospital, KSA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Previously examined the potential of conventional Fourier transform infrared spectroscopy (FTIR) in an attempt to detect specific biomarkers for discrimination between disease free and acute leukemia bone marrow samples. Aim: To assess the efficacy in detecting minimal residual disease in acute leukemia by FTIR. Patient and Methods: Case report, to predict early relapse, and distinguish disease free in remission (control) bone marrow samples, four bone marrow samples were obtained from an 11-year-old boy diagnosed as acute leukemia. Samples (1) and (2) for the patient in remission as diagnosed clinically and laboratory examination free, sample (3) diagnosed relapse in CNS, while sample (4) was taken post-chemotherapy induction. Result: The results revealed that characteristic band alterations arising from cellular protein, lipid, and DNA were identified in both control and diseased samples (relapse of ALL). There were specific changes that affected the secondary structure of proteins and appeared in the FTIR spectra confirmed with the second-derivative analysis. The overall protein structure in the control sample consisted primarily of a-helices, whereas in relapse ALL sample, it had a relatively high proportion of anti-parallel b-sheet protein constituents presumably due to leukemia. Different absorbance ratios for specific bands were calculated and plotted versus the patient’s samples in different time intervals. There are significant fluctuations in the ratios under investigation, which can be attributed to the changes in the biomolecular structure between the control and relapsed samples. These ratios are all yield statistically significant differences in parameters that it can be used as an early predictor of minimal residual disease (MRD) in acute leukemia. Conclusions: Fourier transform infrared spectroscopy is an effective method in detecting minimal residual disease in acute leukemia. Further larger samples is indicated.
Subjects
Paediatrics & NeonatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2017
Detection of Minimal Residual Disease in Childhood B-Acute Lymphoblastic Leukemia by 4-Color Flow Cytometry
Editorial · 2012
Detection and Molecular Monitoring of Minimal Residual Diseases in Acute Myeloid Leukemia’s
Conference abstract
Identification of novel molecular markers for minimal residual disease assessment in acute leukemia
Short communication · 3 Feb 2025
The Role of Minimal Residual Disease Monitoring in Acute Myeloid Leukemia: Redefining Treatment Success
More from this journal
The newest in Pediatrics & Therapeutics.
Conference abstract · 6 Oct 2025
Positive outcome in a patient with hypoplastic left heart syndrome: Key factors for successful survival: A case report
Conference abstract · 6 Oct 2025
Out of Hospital Neonatal Outcomes (OHNO) registry
Conference abstract · 6 Oct 2025
Innovations in Early Diagnosis of Neonatal Sepsis: Advances in Biomarkers and Clinical Protocols
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPediatrics & Therapeutics
- SubjectPaediatrics & Neonatology
- BylineArticles whose byline prints “Soad K Al Jaouni”

